DAX25.121 +3,0%Est506.058 +3,2%MSCI World4.343 -0,1%Top 10 Crypto10,47 +0,7%Nas25.326 +1,0%Bitcoin70.203 +1,7%Euro1,1786 +0,8%Öl97,79 -11,4%Gold4.706 +3,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Infineon 623100 Rheinmetall 703000 SAP 716460 NVIDIA 918422 NEL ASA A0B733 AMD (Advanced Micro Devices) 863186 Novo Nordisk A3EU6F Siemens Energy ENER6Y Lufthansa 823212 Intel 855681 BioNTech (ADRs) A2PSR2 Amazon 906866 Commerzbank CBK100 Deutsche Telekom 555750 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX knackt 25.000er-Marke -- HENSOLDT: Milliarden-Orderbuch sprengt Analysten-Erwartungen -- BMW, RENK, Novo Nordisk, Infineon, VW, AMD und weitere Chipaktien im Fokus
Top News
Ausblick: Airbnb veröffentlicht Zahlen zum vergangenen Quartal Ausblick: Airbnb veröffentlicht Zahlen zum vergangenen Quartal
Neue Analyse: Deutsche Bank AG bewertet Fresenius Medical Care (FMC) St-Aktie mit Hold Neue Analyse: Deutsche Bank AG bewertet Fresenius Medical Care (FMC) St-Aktie mit Hold
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & Musterdepots Tools & integriertes Trading Newsletter, Trading-Desk uvm.
Schon einen Account? Anmelden
Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

AbbVie Aktie

Kaufen
Verkaufen
AbbVie Aktien-Sparplan
175,30 EUR -1,10 EUR -0,62 %
STU
205,62 USD -2,62 USD -1,26 %
vorbörslich
BTT
finanzen.net zero
AbbVie jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.313,80 Mrd. EUR

KGV96,78Div. Rendite2,91%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1J84E

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS00287Y1091

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolABBV

AbbVie Aktien News

DatumMeistgelesen
ZacksHave Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?
ZacksAbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
PR NewswireAbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals
PR NewswireAbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
ZacksAbbVie (ABBV) Gains As Market Dips: What You Should Know
PR NewswireAbbVie Partners with Chicago Cubs on "Striking Out Cancer"
ZacksThe Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands
ZacksTop Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical
ZacksAbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip?
PR NewswireClass Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors - Contact The Gross Law Firm
ZacksIs Trending Stock AbbVie Inc. (ABBV) a Buy Now?
BenzingaAbbVie To Present Cancer Trial Data At Upcoming ASCO Event
PR NewswireAbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio
PR NewswireAbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient
PR NewswireShareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact Levi & Korsinsky about pending Class Action - ABBV
ZacksThe Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
ZacksAbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer
BenzingaExpert Outlook: AbbVie Through The Eyes Of 10 Analysts
ZacksAbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
PR NewswireAbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas
BenzingaA Look Into AbbVie Inc's Price Over Earnings
BenzingaAbbVie Unusual Options Activity
BenzingaCongressional Trading Report: Rep. Jared Moskowitz Bought Over $27K In AbbVie Stock
BenzingaThis House of Representative Just Bought Up To $915K In AbbVie Stock
ZacksThe Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie
PR NewswireAbbVie to Present at the Bank of America Securities Healthcare Conference
MotleyFoolIs the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
PR NewswireRINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
PR NewswireAbbVie Reports First-Quarter 2025 Financial Results
PR NewswireAbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
PR NewswireAbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
PR NewswireAbbVie to Host First-Quarter 2025 Earnings Conference Call
PR NewswireAbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025
PR NewswireAllergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025
PR NewswireELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
PR NewswireAbbVie to Present at the Leerink Partners Global Healthcare Conference
PR NewswireSKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease
PR NewswireAbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
PR NewswireAbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis
PR NewswireAbbVie to Present at the TD Cowen's 45th Annual Health Care Conference

AbbVie News

AbbVie News: auf dieser Seite finden Sie alle AbbVie News und Nachrichten zur AbbVie Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbbVie News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbbVie News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.